1. Introduction {#s0005}
===============

Corticosteroids and stimulants are the class of compounds that are illicitly used by professionals owing to their anti-inflammatory and mood elevating as well as euphoric properties respectively. They are widespread abused among sports persons [@bib1], stimulant addiction among teenagers and deliberate counterfeiting in herbal products to enhance their effects [@bib2], [@bib3]. Hence there is a need for more sensitive analytical tools to detect and confirm these classes of drugs in biological fluids [@bib3], [@bib4]. These analytical tools would serve to fulfill demands in forensic, toxicological and food safety departments. Glucocorticoid belongs to steroid family, particularly of pregnane class containing C-21 derivatives. Glucocorticoids have important functions upon carbohydrate, protein and calcium metabolism, potent anti-inflammatory and immunosuppressive activities [@bib5], [@bib6], [@bib7], [@bib8]. The activity of glucocorticoids largely depends upon the substituent attached to the nucleus. Substituent has been found to significantly increase both glucocorticoids and mineralocorticoids activities. It has been found that Δ^1,\ 2^ corticosteroids enhance anti-inflammatory activity and decrease salt retaining activity [@bib9]. Some selected glucocorticoids and their structures are shown in [Table 1](#t0005){ref-type="table"}. Stimulants are the class of drugs that have a marked effect on mental function and behavior, producing euphoria and reduced fatigue. They are diverse class of compounds that exhibit their action through different mechanism. This class of drugs is often abused by teenagers leading to addiction and risk of health hazards. Some of selected stimulants are modafinil, famprofazone, tuaminoheptane, amiphenazole, amphetamine, methamphetamine, dimethylamphetamine, methylphenidate, 3,4-methylene-dioxy-N-amphetamine, 3,4-methylene-dioxy-N-ethylamphetamine, strychnine and 3,4-methylene-dioxy-N-methamphetamine etc.Table 1General nucleus of corticoids and different substitutions of different glucocorticoids drugs.![](fx1.gif).Steroid nameΔ^1,\ 2^R~6~R~9~R~11~R~16~R~17~R~21~HydrocortisoneSaturated3H3H3--OH3H3--OH3--OHCortisoneSaturated3H3HåO3H3--OH3--OHCorticosteroneSaturated3H3H3--OH3H3H3--OHFludrocortisoneSaturated3H3F3--OH3H3--OH3--OHPrednisoloneDouble bond3H3H3--OH3H3--OH3--OHPrednisoneDouble bond3H3HåO3H3--OH3--OHMethylprednisoloneDouble bond3--CH~3~3H3--OH3H3--OH3--OHPrednisolone acetateDouble bond3H3H3--OH3H3--OH3--OCOCH~3~DexamethasoneDouble bond3H3F3--OH![](fx2.gif) (á isomer)3--OH3--OHBetamethasoneDouble bond3H3F3--OH![](fx2.gif) (â isomer)3--OH3--OHBeclomethasoneDouble bond3H3Cl3--OH![](fx2.gif) (â isomer)3--OH3--OHTriamcinoloneDouble bond3H3F3--OH3--OH3--OH3--OHTriamcinolone acetonideDouble bond3H3F3--OH![](fx3.gif)3--OH

Thus there is need for sophisticated and robust analytical strategy to confirm their presence in biological fluids. A number of different analytical approaches are available for this purpose. Analytical techniques such as high performance liquid chromatography (HPLC), ultra high performance liquid chromatography (UHPLC), mass spectrometry, gas chromatography, electrochemical detection and enhanced confirmatory procedures are used in detection of these classes of drugs. Recent development and advancement in analytical technologies has emerged with more sophisticated hyphenated techniques, to detect nanograms of drugs or their metabolites in biological fluids. Among hyphenated techniques, LC--MS/MS is the choice of interest because it is highly sophisticated and considerably powerful tool for detection of low and high molecular weight analytes. New methods have enabled the determination of drugs that were formerly difficult to detect by conventional methods of analysis as well as time consuming procedures have been replaced by faster, more comprehensive and robust assays. Good sensitivity and high throughput are key factors for the LC--MS/MS approaches used in drug analysis.

In this review, we present an overview of the methodologies that are reported in literature for detection, confirmation of corticosteroids and stimulants in biological fluids. Reported screening methods using LC--MS/MS approach highlight chromatographic separation and different modes of instrumental acquisition (selective ion monitoring (SIM), multiple reaction monitoring (MRM), precursor ion scan) for MS detection. Proposed mass fragmentation pathways of selected drugs are incorporated in this review.

2. Screening methods for detection of glucocorticoids and stimulants in biological fluids using liquid chromatography mass spectrometry {#s0010}
=======================================================================================================================================

LC--MS/MS techniques provide specific, selective and sensitive quantitative results with reduced sample preparation. Other techniques such as electrochemical detection were also explored for the analysis of drugs. Goyal et al. [@bib10], [@bib11] investigated electrochemical behavior of dexamethasone and triamcinolone at the fullerene-C60-modified pyrolytic graphite electrode (PGE) using Osteryoung square wave voltammetry (SWV) and they illustrated quantitative determination of dexamethasone and triamcinolone in several commercially available pharmaceutical formulations and human blood plasma of patients being treated with dexamethasone. LC--MS/MS is currently most ideal tools for screening and quantifying corticosteroids in biological fluids as compared to other conventional techniques. This technique is widely used for pharmacokinetic (PK) studies, metabolites identification in plasma and urine, doping analysis and forensic studies. The introduction of commercial hyphenated instruments in which liquid chromatography is coupled with different mass analyzers such as time of flight mass spectrometry (LC--TOFMS), triple quadrupole mass spectrometer and soft ionization techniques \[electrospray ionization (ESI), atmospheric pressure chemical ionization (APCI), atmospheric pressure photo ionization (APPI), and matrix assisted laser desorption ionization (MALDI) etc.\] has simplified the laboratory analysis and also decreased the cost of analysis to some extent. The polarity and functionalities of corticosteroids and stimulants allow the use of ionization techniques in positive ion or negative ion modes and different modes of instrumental acquisition for mass detection. [Table 2](#t0010){ref-type="table"}, [Table 3](#t0015){ref-type="table"} summarize the information on methods used for identification and confirmation of corticosteroids [@bib12], [@bib13], [@bib14], [@bib15], [@bib16], [@bib17], [@bib18], [@bib19], [@bib20], [@bib21], [@bib22], [@bib23], [@bib24], [@bib25] and selected stimulants [@bib26], [@bib27], [@bib28], [@bib29], [@bib30].Table 2Selected confirmatory methods for detecting glucocorticoids in biological fluids.AnalyteMatrixPretreatmentColumn; mobile phaseDetection modeLODRef.9 Synthetic corticosteroidsUrineLLE with Extrelut-NT3 columnsInertsil ODS-3 C18 column (150 mm×3 mm, 3 μm); 1 mM ammonium acetate pH 6.8/ACN (60:40, v/v) at 0.4 mL/minESI negative SIM mode1 ng/mL[@bib12]20 CorticosteroidsUrineEnzymatic hydrolysis C-8 SCX SPE CartridgeSupelcosil LC-8-DBcolumn (2.1 mm×3.3 cm, 3 μm); 5 mM acetic acid/10 mM ammonium acetate (pH 3.8)/methanol, at 0.2 mL/minESI positive MRM0.1--10 ng/mL[@bib13]Methylprednisolone methylprednisolone acetatePlasmaProtein precipitationSinergy Max RP C-12 column (2.0 mm×150 mm, 4 μm); 0.01% formic acid in water/ACN (50:50, v/v) at 0.2 mL/minESI positive MRM6--300 ng/mL[@bib14]17 Synthetic glucocorticoidsUrineEnzymatic hydrolysis followed by LLEBEH C18 column(2.1 mm×50 mm, 1.7 μm); 0.1% formic acid in ACN/0.1% formic acid in water, at 0.35 mL/minTOF-MS with ESI positive0.1--3.3 μg/L[@bib15]MethylprednisoloneMethylprednisolone PlasmaLLEPursuit C-18 column (2.0 mm×150 mm, 5 μm); ACN/0.5% formic acid aq. solution (85:15, v/v) at 0.2 mL/minESI positive SRM20--2000 ng/mL[@bib16]5 Corticosteroids: dexamethasone, flumethasone, fluorometholone, beclomethasone, triamcinolone acetonideUrineEnzymatic hydrolysis Oasis-HLB SPE columnAlltima C-18 column (2.1 mm × 150 mm, 5 µm); ACN/water(40:60, v/v) at 0.3 mL/minAPCI positive SRM mode2--3 ng/mL[@bib17]Cortisol, cortisone, prednisolone, prednisonePlasmaProtein precipitationZorbax-SB phenyl, HT rapid resolution column (2.1 mm×100 mm, 1.8 μm); ACN/H~2~O/ formic acid(32:68:0.1, v/v) at 0.140 mL/minAPCI positive MRM mode0.5--2 ng/mL[@bib18]Prednisone, prednisolone, dexamethasone, cortisolHuman serumSPESymmetry C-18 column (2.1 mm×30 mm, 3.5 μm); methanol/5 mM acetate buffer pH 3.25 at 400 μL/minESI negative MRM mode0.2--0.5 ng/mL[@bib19]Cortisol, dexamethasone, prednisone, prednisolone, methylprednisolonePlasmaSPE Oasis HLB CartridgeSymmetry C-18 column (2.1 mm×30 mm, 3.5 μm); 5 mM ammonium acetate buffer pH 3.5 and methanol (95:5, v/v)/methanol and 5 mM ammonium acetate buffer pH 3.5 (95:5, v/v), at 400 μL/minESI negative MRM mode3--7 ng/mL[@bib20]21 Synthetic corticosteroidsUrineEnzymatic hydrolysis followed by LLERP DB-8 column (4.6 mm×75 mm, 3 μm); 1% acetic acid/ methanol, at 1 mL/minAPCI positive full scan mode5 ng/mL[@bib21]Cortisol, cortisone, prednisolone, dexamethasone, 11-deoxycortisolPlasma, urine saliva, plasma-ultra filtrateSPE Oasis HLB 1 cm^3^ CartridgeAcquity UPLC BEH C-18 column (2.1 mm×50 mm, 1.7 μm); *A*=2 mM ammonium acetate in water with 0.1% formic acid, *B*=2 mM ammonium acetate in methanol with 0.1% formic acid, at 0.4 mL/min, total run time 3 min.ESI positive MRM0.6--5 nM[@bib22]16 GlucocorticoidsUrineEnzymatic hydrolysis followed by LLEHalo C-18 column(2.1 mm×150 mm, 2.7 μm and 2.1 mm×100 mm, 2.7 μm); water with 0.1% formic acid/ACN with 0.1% formic acid at 400 μL/minESI positive MRM5--15 ng/mL[@bib23]15 Synthetic glucocorticoidsUrineEnzymatic hydrolysis followed by LLEZorbax C-18 column (2.1 mm×50 mm, 1.8 μm); 0.1% acetic acid/ACN with 0.1% acetic acid at 0.3 mL/minESI positive MRM1--30 ng/mL[@bib24]14 GlucocorticoidsUrineEnzymatic hydrolysis followed by LLEInertsil ODS-3 C18 column(50 mm×4.6 mm, 3 μm); 1% formic acid/ACN, at 700 μL/minESI positive MRM1--5 ng/mL[@bib25][^1]Table 3Selected confirmatory methods for detecting stimulants in biological fluids.AnalyteMatrixPretreatmentColumn; Mobile phaseDetection modeLODRef.9 Stimulants including strychnine, methylphenidate, amiphenazole, famprofazone, tuaminoheptanUrineEnzymatic hydrolysis followed by LLEHalo C-18 column (2.1 mm ×150 mm, 2.7 μm and 2.1 mm×100 mm, 2.7 μm); water with 0.1% formic acid/ACN with 0.1% formic acid at 400 μL/minESI positive MRM70--300 ng/mL[@bib23]Mesocarb, modafinil, formoterolUrineEnzymatic hydrolysis followed by LLEZorbax C-18 column (2.1 mm×50 mm,1.8 μm); 0.1% acetic acid/ACN with 0.1% acetic acid at 0.3 mL/minESI positive MRM100--200 ng/mL[@bib24]Methylphenidate, mesocarbUrineEnzymatic hydrolysis followed by LLEInertsil ODS-3 C18 column(50 mm×4.6 mm, 3 μm); 1% formic acid/ACN, at 700 μL/minESI positive MRM5 ng/mL[@bib25]49 StimulantsUrineEnzymatic hydrolysis SPE cartridgePhenomex Luna C-18 column( 2 mm ×100 mm, 3 μm); 5 mM ammonium acetate with 0.1% formic acid/ ACN, at 0.3 mL/minESI positive0.025 μg/mL[@bib26]27 Amphetamine and amphetamine like drugsUrineLLEOmnispher C-18 column (3.0 mm×50 mm, 3 μm); 0.1% formic acid/methanol, at 0.4 mL/minAPCI positive full scan MS1--25 ng/mL[@bib27]7 Amphetamine derivatives: AP, MA, MDA, MDMA,MDEA, DMA, DMANOUrineOasis HLB SPECapcell C-18 MG-II column (2.0 mm×150 mm, 5 μm); 5 mM ammonium formate pH 4.0/ACN, at 230 μL/minESI positive MRM1.95 ng/mL[@bib28]MesocarbUrineEnzymatic hydrolysis followed by LLEThermo-Hyper Gold C-18 (2.1 mm×50 mm, 3 μm ); 15 mM ammonium formate containing 1% formic acid/ACN at 200 μL/minSRM positive5 ng/mL[@bib29]AP, MA, MDA, MDMA, MDEA, PMA, ephedrineUrineLLEAcquity UPLC HSS C-18 column(2.1 mm×100 mm, 1.8 μm ); 5 mM ammonium formate buffer containing 0.05% formic acid/methanol, at 0.3 mL/minESI positive MRM0.5--2.5 ng/mL[@bib30][^2]

Fluri et al. [@bib12] reported confirmatory method for 11 corticosteroids in urine samples based on LC--ESI--MS. The selective and sensitive method for confirmation and identification of nine synthetic corticosteroids assured the exclusion of false positive results obtained by corticosteroid group ELISA screening tests. Emmie et al. [@bib13] developed two high throughput LC--MS methods for the screening of anabolic steroids, corticosteroids, and acidic drugs using a high efficiency LC column coupled with a fast scanning triple quadrupole mass spectrometer. The detection of 40 anabolic steroids, corticosteroids, and 52 acidic drugs were achieved within a 6.5 min and a 4.5 min LC--MRM run, respectively and all the targets were detected at low amount. Validation data showed that both methods have acceptable precision to be used on a routine basis and no interference from sample matrix was observed.

A rapid, sensitive and specific method for the simultaneous detection and quantization of methylprednisolone acetate (MPA) and methylprednisolone (MP) in rat plasma, using a triple stage quadrupole was developed and validated by Panusa et al. [@bib14] using LC--ESI--MS/MS. Its excellent applicability in PK studies was demonstrated. It was proved to be highly sensitive, allowing detection and quantization of the analytes at lower concentrations.

Method was developed by Touber et al. [@bib15] using the latest high-resolution LC column technology, UPLC™, and ESI interface in the positive ion mode. Gradient UPLC separation conditions were optimized for a group of 22 analytes including 17 glucocorticosteroids. The UPLC--TOF--MS separation obtained required 5.5 min only for all the substances tested. Even the critical pair of dexamethasone and betamethasone isomers was almost completely resolved. The authors recommended that dedicated UPLC--TOF--MS criteria regarding the number of identification points (IPs), mass accuracy of parent, fragment ions, ion ratio, and relative retention time have not been assessed, in order to allow application of this new technology for confirmation of identity as well, that should be considered and thus needs improvement.

Mazzarino et al. [@bib23] performed screening of several classes of substances in a single chromatographic method with a run-time of 11 min, inclusive of post-run and reconditioning times. The effectiveness of this approach was evaluated by LC--ESI--MS/MS in the positive mode, using 20 blank urine samples spiked with 45 compounds prohibited in sport including 16 glucocorticoids and 9 stimulants. All of the analytes were clearly distinguishable in urine, with limits of detection ranging from 5 ng/mL to 350 ng/mL. All the compounds of interest were separated, including synthetic and endogenous glucocorticoids with similar retention times and fragmentation patterns.

Kolmonen et al. [@bib26] developed a general screening method based on solid phase extraction (SPE), LC--TOF/MS and validated 124 different doping agents including stimulants in urine. The result indicated that compared with conventional doping control methods, this method was more flexibility in identification, database management and reduced the time required for analysis.

A selective and sensitive method for the qualitative screening of urine samples for 27 amphetamine and amphetamine-type drugs was described by Deventer et al. [@bib27] using mass spectrometer equipped with APCI interface, operated in positive ionization mode. They reported that the amount of urine routinely used in their laboratory for the extraction of these stimulants (5 mL) was reduced to 2 mL and thus reduced sample volume. The detection limits for all the compounds were lower than 25 ng/mL except for chlorphentermine, thus it was good alternative to gas chromatography with nitrogen phosphorus detector (GC-NPD).

Kim et al. [@bib28] developed and validated LC--ESI--MS/MS method for the simultaneous detection and quantification of seven amphetamine derivatives amphetamine (AP), methamphetamine (MA), 3,4-methylenedioxy-N-amphetamine (MDA), 3,4-methylenedioxy-*N*-methamphetamine (MDMA), 3,4-methylenedioxy-N-ethylamphetamine (MDEA), N,N-dimethylamphetamine (DMA) and N,N-dimethylamphetamine-N-oxide (DMANO) in human urine. The paper reported that the SPE step was assayed to detect and quantify seven target analytes in urine samples without any significant interference from the matrix components.

Counterfeiting of herbal drugs with synthetic agents can also be detected by LC--MS/MS [@bib31], [@bib32]. Different mass analyzers (TOF, IT (ion trap)) have been coupled with LC and extensively used for screening and characterization of different analytes in plasma and herbal extracts [@bib33], [@bib34].

3. Focusing on different strategies for detection of glucocorticoids and stimulants in biological fluids {#s0015}
========================================================================================================

Based on the reported MS-fragmentation data, a common fragmentation could be developed in screening of corticosteroids and stimulants. The basic information regarding empirical formula, exact masses, Log *P* and absorption maxima (*λ*~*max*~) is also summarized in [Table 4](#t0020){ref-type="table"}. *P* and Log *P* are partition coefficient or logarithm of the partition coefficient of a drug. These parameters express the relative distribution of drug between oil and water under specified conditions for example, octanol/water at 37 °C and pH 7.4. Drugs with higher *P* or Log *P* are more lipophilic, generally distribute more rapidly and to a greater degree into bodily tissues and fluids. These physicochemical properties help in prediction of drug transport. These data render to presume interaction of analyte with stationary phase, thereby allowing a good evaluation of its chromatographic performance. UV spectra can help as a preliminary screening to distinguish different analytes on the basis of their absorption maxima (*λ*~*max*~). The super-imposable nature of UV spectra of an analyte with a certified reference material (CRM) can give fair idea about their structural similarity to much extent. This approach has been employed for detection of adulteration using HPLC with UV detector.Table 4Empirical formula, exact masses, MS fragmentation data, Log *P* and *λ*~*max*~ of selected glucocorticoids and stimulants.Drug nameEmpirical formulaExact mass\[M+H\]^+^m/z of major fragments reportedLog *P*[a](#tbl4fna){ref-type="table-fn"}*λ*~*max*~ (nm)Ref.AmphetamineC~9~H~13~N135.10480136.2119.2, 91.21.8257, 263[@bib28]MDAC~10~H~13~NO~2~179.09463180.2163, 134.9, 1051.64233, 285[@bib28], [@bib30]MDMAC~11~H~15~ NO~2~193.11028194.1163.2, 105.12.15234, 285[@bib28], [@bib30]BeclomethasoneC~22~H~29~ClO~5~408.17035409.18391, 373, 3372.03239[@bib17], [@bib24]BetamethasoneC~22~H~29~FO~5~392.19990393337, 355, 241, 1471.94240[@bib24], [@bib25], [@bib35], [@bib37]BudesonideC~25~H~34~O~6~430.23554431413, 341, 323, 1732.18248[@bib24], [@bib32], [@bib36], [@bib37]DexamethasoneC~22~H~29~FO~5~392.19990393373, 355, 337, 237, 1471.83240[@bib17], [@bib24], [@bib35], [@bib37]FludrocortisoneC~21~H~29~FO~5~380.19990381343, 2391.67240[@bib24], [@bib36]FlumethasoneC~22~H~28~F~2~O~5~410.19047411371, 335, 253, 1211.9238[@bib17], [@bib24], [@bib32], [@bib35]FluocortoloneC~22~H~29~FO~4~376.20499377321, 3032.1242[@bib24]MethylphenidateC~14~H~19~NO~2~233.14158234174, 129, 84, 560.20264[@bib23], [@bib25], [@bib35]MethylprednisoloneC~22~H~30~O~5~374.20932375357, 339, 1611.82240[@bib16], [@bib25], [@bib36], [@bib37]PrednisoloneC~21~H~28~O~5~360.19367361343, 325, 147, 3071.62240[@bib24], [@bib25], [@bib35], [@bib36], [@bib37]PrednisoneC~21~H~26~O~5~358.17802359341, 323, 267, 147, 341.46240[@bib24], [@bib25], [@bib35], [@bib36], [@bib37]StrychnineC~21~H~22~N~2~O~2~334.16813335264, 184, 1561.9255[@bib21], [@bib23]TriamcinoloneC~21~H~27~FO~6~394.17917395357, 321, 2251.16238[@bib24], [@bib25], [@bib36], [@bib37]TriamcinoloneC~24~H~31~FO~6~434.21047435415, 397, 2131.2238[@bib24], [@bib25], [@bib36], [@bib37]Acetonide[^3]

The precursor and products ions summarized in [Table 4](#t0020){ref-type="table"}, are based on positive ionization. Depending upon the nature of target analytes, ionization mode is optimized. Fluri et al. [@bib12] studied both negative and positive ionization modes for examined glucocorticoids. Due to less fragmentation and a better signal-to-noise ratio (4:1), sensitivity increased for measurements in the negative ionization mode. They assessed that fragmentation of corticosteroids in the ESI negative mode is simple as few ions were produced. The products ions of ten selected corticosteroids by their study are presented in [Table 5](#t0025){ref-type="table"}.Table 5Characteristics fragment ions of glucocorticoids obtained in ESI negative mode LC--MS/MS.Analyte*m*/*z* fragmentsCortisone329.2[a](#tbl5fna){ref-type="table-fn"}, 301.2, 311.2Dexamethasone361.2[a](#tbl5fna){ref-type="table-fn"}, 307.2, 325.2Hydrocortisone331.2[a](#tbl5fna){ref-type="table-fn"}, 297.2, 282.2Flumethasone379.2[a](#tbl5fna){ref-type="table-fn"}, 325.2, 305.2Flunisolide375.2[a](#tbl5fna){ref-type="table-fn"}, 357.2, 433.2Methylpednisolone343.2[a](#tbl5fna){ref-type="table-fn"}, 309.2, 294.2Prednisolone329.2[a](#tbl5fna){ref-type="table-fn"}, 295.2, 280.2Prednisone327.2[a](#tbl5fna){ref-type="table-fn"}, 299.2, 285.2Triamcinolone345.2[a](#tbl5fna){ref-type="table-fn"}, 325.2, 393.2Triamcinolone acetonide413.2[a](#tbl5fna){ref-type="table-fn"}, 337.2, 375.2, 469.2[^4]

4. Proposed mass fragmentation pattern {#s0020}
======================================

The hypothetical mass fragmentation pattern of some selected drugs like dexamethasone, prednisolone, prednisone and strychnine on the basis of MRM transitions has been incorporated and that helps in confirmation of analytes on the basis of diagnostic ions ([Fig. 1](#f0005){ref-type="fig"}, [Fig. 2](#f0010){ref-type="fig"}, [Fig. 3](#f0015){ref-type="fig"}, [Fig. 4](#f0020){ref-type="fig"}). The daughter ions generated from the parent ions help to predict the fragmentation pattern of the molecule and are useful in confirmation of the target analytes.Fig. 1Proposed mass fragmentation pathway of dexamethasone drug. 1---Molecular ion peak at M^+^=393. 2---Base ion peak at *m*/*z*=373. 3---Daughter ion peak at *m*/*z*=355.Fig. 2Proposed mass fragmentation pathway of prednisolone drug. 1---Molecular ion peak at M^+^=361. 2---Base ion peak at *m*/*z*=343. 3---Daughter ion peak at *m*/*z*=307.Fig. 3Proposed mass fragmentation pathway of prednisone drug. 1---Molecular ion peak at M^+^=359. 2---Base ion peak at *m*/*z*=341. 3---Daughter ion peak at *m*/*z*=171.Fig. 4Proposed mass fragmentation pathway of strychnine drug. 1---Molecular ion peak at M^+^=335. 2---Base ion peak at *m*/*z*=264. 3---Daughter ion peak at *m*/*z*=156.

5. Conclusion {#s0025}
=============

With the advancement of hyphenated techniques, high resolution mass analyzers as well as high throughput separation approaches, quantitative analysis of glucocorticoids and stimulants can be achieved with good sensitivity. Newer methods can be developed for routine analysis of target analytes in biological fluids with shorter run time and good detectability. Application of new fused core columns for their effectiveness and use of both positive and negative polarities in a single run need to explore.
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[^1]: Ref.---References.

[^2]: AP: amphetamine, MA: methamphetamine, MDA: 3,4-methylenedioxy-N-amphetamine, DMA: N, N-dimethylamphetamine, PMA: p-hydroxymethamphetamine, MDMA: 3,4-methylenedioxy-N-methamphetamine, MDEA: 3,4-methylenedioxy-N-ethylamphetamine, DMANO: N, N-dimethyl amphetamine-N-oxide, SPE: solid phase extraction, LLE: liquid--liquid extraction, ACN: acetonitrile, Ref: references.

[^3]: Values obtained from online SRC Phys Prop Database, Ref.---References.

[^4]: Indicate base peak.
